MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer.

Sung-Hsin KuoMing-Feng WeiYi-Hsuan LeeJui-Chueh LinWen-Chi YangShi-Yi YangChiun-Sheng Huang

Published in: Cellular oncology (Dordrecht) (2023)

Our results indicate that the overexpression of MAP3K1 plays a major role in the poor prognosis of HR-positive, HER2-negative early stage breast cancer.

Keyphrases

poor prognosis
early stage
long non coding rna
sentinel lymph node
high density
squamous cell carcinoma
radiation therapy